Last reviewed · How we verify
Hypercholesterolemic diet
At a glance
| Generic name | Hypercholesterolemic diet |
|---|---|
| Sponsor | Universidad Miguel Hernandez de Elche |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Functional Cereal Products and Contribution to the Regulation of Metabolism and Obesity-induced Chronic Low-grade Inflammation. (NA)
- Evaluating the Efficacy of AI-Guided (GenAIS TM) vs. Standard Physician-Guided Dietary Supplement Prescriptions for Lowering LDL Cholesterol in Hypercholesterolemic Patients (NA)
- Lipid-lowering Effect of Phytosterols, Red Yeast Rice and Their Combination (NA)
- Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia (NA)
- Effect of Oleactiv® on LDL Oxidability (NA)
- Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects (NA)
- Effects of Black Tea Intake on Serum Lipids (NA)
- Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hypercholesterolemic diet CI brief — competitive landscape report
- Hypercholesterolemic diet updates RSS · CI watch RSS
- Universidad Miguel Hernandez de Elche portfolio CI